Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

SHSE:600196 Stock Report

Market Cap: CN¥65.1b

Shanghai Fosun Pharmaceutical (Group) Dividends and Buybacks

Dividend criteria checks 2/6

Shanghai Fosun Pharmaceutical (Group) is a dividend paying company with a current yield of 1.03% that is well covered by earnings.

Key information

1.0%

Dividend yield

-0.08%

Buyback Yield

Total Shareholder Yield0.9%
Future Dividend Yield2.1%
Dividend Growth0.1%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.270
Payout ratio34%

Recent dividend and buyback updates

Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Is Paying Out Less In Dividends Than Last Year

Aug 03
Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Is Paying Out Less In Dividends Than Last Year

Recent updates

There May Be Some Bright Spots In Shanghai Fosun Pharmaceutical (Group)'s (SHSE:600196) Earnings

Nov 05
There May Be Some Bright Spots In Shanghai Fosun Pharmaceutical (Group)'s (SHSE:600196) Earnings

Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Is Paying Out Less In Dividends Than Last Year

Aug 03
Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Is Paying Out Less In Dividends Than Last Year

Here's Why Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Has A Meaningful Debt Burden

Jul 28
Here's Why Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) Has A Meaningful Debt Burden

Market Still Lacking Some Conviction On Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196)

May 23
Market Still Lacking Some Conviction On Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196)

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Just Missed EPS By 15%: Here's What Analysts Think Will Happen Next

May 01
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Just Missed EPS By 15%: Here's What Analysts Think Will Happen Next

We Think You Can Look Beyond Shanghai Fosun Pharmaceutical (Group)'s (SHSE:600196) Lackluster Earnings

Apr 02
We Think You Can Look Beyond Shanghai Fosun Pharmaceutical (Group)'s (SHSE:600196) Lackluster Earnings

Is Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) A Risky Investment?

Mar 18
Is Shanghai Fosun Pharmaceutical (Group) (SHSE:600196) A Risky Investment?

Are Investors Undervaluing Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) By 48%?

Feb 26
Are Investors Undervaluing Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) By 48%?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 600196's dividend payments have been volatile in the past 10 years.

Growing Dividend: 600196's dividend payments have not increased over the past 10 years.


Dividend Yield vs Market

Shanghai Fosun Pharmaceutical (Group) Dividend Yield vs Market
How does 600196 dividend yield compare to the market?
SegmentDividend Yield
Company (600196)1.0%
Market Bottom 25% (CN)0.5%
Market Top 25% (CN)2.1%
Industry Average (Pharmaceuticals)1.7%
Analyst forecast (600196) (up to 3 years)2.1%

Notable Dividend: 600196's dividend (1.03%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).

High Dividend: 600196's dividend (1.03%) is low compared to the top 25% of dividend payers in the CN market (2.08%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (34.3%), 600196's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: 600196 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies